EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current advances and future directions in targeting histone demethylases for cancer therapy

June-Ha Shin, Hye-Been Yoo, Jae-Seok Roe

Molecules and Cells · 2025-03 · 48 (3) · 100192

DOI: 10.1016/j.mocell.2025.100192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules and Cells, 2025-03. Verfasst von June-Ha Shin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Histone Demethylases, Neoplasms, Molecular Targeted Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic regulators, known as "writers," erasers," and "readers," are essential for controlling gene expression by adding, removing, or recognizing post-translational modifications to histone tails, respectively. These regulators significantly affect genes involved in cancer initiation and maintenance. Recently, several clinical strategies targeting these epigenetic enzymes have emerged and some trials have demonstrated promising results for cancer treatment. Histone lysine demethylases (KDMs) yield distinct transcriptional outcomes that depend on the position of the methylated lysine and the specific genotype or lineage of the cancer cells. Due to their diverse roles in transcription, KDMs offer valuable opportunities for precision oncology, allowing treatments to be tailored to meet individual patient needs. This review emphasizes our current understanding of the functional relationship between KDMs and cancer as well as the development and application of small-molecule compounds that target KDMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone DemethylasesNeoplasmsMolecular Targeted TherapyHumansAnimalsEpigenesis, GeneticHistonesProtein Processing, Post-Translational

Stichwörter der Autor:innen

CancerEpigeneticsHistone modificationLysine demethylase

Substanzen

Histone DemethylasesHistones

Autor:innen und Institutionen

  • Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea. Electronic address: jroe@yonsei.ac.kr.

Zitieren

APA

Shin, J. H., Yoo, H. B., & Roe, J. S. (2025). Current advances and future directions in targeting histone demethylases for cancer therapy. Molecules and Cells, 48(3), 100192. https://doi.org/10.1016/j.mocell.2025.100192

Vancouver

Shin JH, Yoo HB, Roe JS. Current advances and future directions in targeting histone demethylases for cancer therapy. Molecules and Cells. 2025;48(3):100192. doi:10.1016/j.mocell.2025.100192

BibTeX
@article{Shin2025,
  author = {Shin, June-Ha and Yoo, Hye-Been and Roe, Jae-Seok},
  title = {Current advances and future directions in targeting histone demethylases for cancer therapy},
  journal = {Molecules and Cells},
  year = {2025},
  volume = {48},
  number = {3},
  pages = {100192},
  doi = {10.1016/j.mocell.2025.100192}
}
Kostenlos starten →